| Website | nbgipe.com/ventures |
| Employees | |
| Founded | 2001 |
| Description | Medtech Venture Capital Fund |
| French fund I, 1/10 | €100M |
NBGI Ventures is a leading venture capital fund focused on investing in exceptional medical technology companies. Established in 2001, NBGI Ventures currently manage two funds with over $100 million in total commitments and invest from greenfield start-ups to mature companies.
NBGI Ventures have offices in London and Athens, and have invested in a portfolio of companies across Europe in all med-tech subsectors. The investment team consists of experienced, down-to-earth and active professionals committed to identifying innovators and supporting their growth.
NBGI Ventures is part of the NBGI Private Equity group, a leading European private equity and venture capital investment firm managing approximately €800 million.
| Company | Date | Round | Size | Participants |
| DySISmedical | 4/13 | Venture Round | £7.4M | 4 |
| SuperSonic Imagine | 4/13 | Private Equity | €28M | 9 |
| CellNovo | 2/11 | Series B | £30M | 8 |
| Estech | 12/10 | Series D | $8.5M | 4 |
| SuperSonic Imagine | 11/10 | Series C | €34.5M | 6 |
| Reverse Medical | 4/10 | Series B | $14M | 6 |
| Advanced Cardiac Therapeutics | 1/10 | Series B | $5M | 1 |
| Quanta Fluid Solutions | 11/09 | Series A | $14.3M | 4 |
| Estech | 6/09 | Series B | $19.3M | 4 |
| Upfront Chromatography | 9/07 | Venture Round | $9.2M | 3 |
| BONESUPPORT | 11/06 | Venture Round | kr135M | 6 |